Furosemide Tablets BP (Vet) 20 mg

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Active ingredient:

Furosemide

Available from:

Millpledge Ltd

ATC code:

QC03CA01

INN (International Name):

Furosemide

Pharmaceutical form:

Tablet

Prescription type:

POM-V - Prescription Only Medicine – Veterinarian

Therapeutic group:

Cats, Dogs

Therapeutic area:

Cardio Vascular diuretic

Authorization status:

Authorized

Authorization date:

1998-09-10

Summary of Product characteristics

Revised: April 2021
AN: 00991/2020
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Furosemide Tablets BP (Vet) 20 mg
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE INGREDIENTS
Furosemide (The recommended INN and European
Pharmacopoeia title of Frusemide B.P. is Furosemide
20mg)
OTHER INGREDIENTS
For full list of excipients see section 6.1
3.
PHARMACEUTICAL FORM
Tablet – Oral Tablets containing the stated amount of Furosemide.
Flat faced,
white circular with bevelled edges and a scored half break line,
embossed F20
and plain on the reverse.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dog and cat.
4.2
INDICATIONS FOR USE
For the treatment of oedema, the product may be used in ascites,
hydrothorax,
pulmonary oedema of the mammary glands or legs, as well as oedema
resulting
from cardiac insufficiency, hepatic or renal dysfunction, parasitism
or of a
traumatic origin.
4.3
CONTRA-INDICATIONS
Do not use in acute glomerular nephritis, in electrolyte diseases, in
patients with
anuria, or patients that have received excessive doses of cardiac
glycosides.
Because of the danger of potentiating their toxic effects do not use
with
aminoglycoside or cephalosporin antibiotics. Allergic reactions have
been
associated with use with sulphonamides.
Revised: April 2021
AN: 00991/2020
Page 2 of 4
4.4
SPECIAL WARNINGS
The patient may increase its water intake to compensate for the
diuresis.
Consideration should be given to restricting water intake if the
patient’s condition
makes such a course appropriate.
4.5 SPECIAL PRECAUTIONS
4.5.1
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Prolonged dosage may on occasions justify potassium supplementation
and
thus monitoring for hypokalaemia should be considered, especially if
the product
is used in conjunction with cardiac glycosides.
4.5.2
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
MEDICINAL
PRODUCT TO ANIMALS:
Wear gloves or wash hands immediately after handling tablets. In case
of
accidental ingestion seek medical attention an